Arcus Biosciences Stock Price History
| RCUS Stock | USD 15.43 0.07 0.45% |
Below is the normalized historical share price chart for Arcus Biosciences extending back to March 15, 2018. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Arcus Biosciences stands at 15.43, as last reported on the 25th of April, with the highest price reaching 15.85 and the lowest price hitting 14.71 during the day.
If you're considering investing in Arcus Stock, it is important to understand the factors that can impact its price. We consider Arcus Biosciences not too volatile. Arcus Biosciences secures Sharpe Ratio (or Efficiency) of 0.0281, which signifies that the company had a 0.0281% return per unit of standard deviation over the last 3 months. We have found twenty-nine technical indicators for Arcus Biosciences, which you can use to evaluate the volatility of the firm. Please confirm Arcus Biosciences' risk adjusted performance of 0.0258, and Mean Deviation of 2.93 to double-check if the risk estimate we provide is consistent with the expected return of 0.12%.
At this time, Arcus Biosciences' Common Stock is comparatively stable compared to the past year. Capital Stock is likely to gain to about 1.4 B in 2024, whereas Common Stock Shares Outstanding is likely to drop slightly above 57.8 M in 2024. . At this time, Arcus Biosciences' Price Book Value Ratio is comparatively stable compared to the past year. Price To Book Ratio is likely to gain to 3.39 in 2024, despite the fact that Price Earnings Ratio is likely to grow to (4.37). Arcus Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 15th of March 2018 | 200 Day MA 17.5954 | 50 Day MA 17.4476 | Beta 0.851 |
Arcus |
Sharpe Ratio = 0.0281
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | RCUS | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 4.37 actual daily | 38 62% of assets are more volatile |
Expected Return
| 0.12 actual daily | 2 98% of assets have higher returns |
Risk-Adjusted Return
| 0.03 actual daily | 2 98% of assets perform better |
Based on monthly moving average Arcus Biosciences is performing at about 2% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Arcus Biosciences by adding it to a well-diversified portfolio.
Price Book 3.2609 | Enterprise Value Ebitda (2.61) | Price Sales 12.8764 | Shares Float 54.4 M | Wall Street Target Price 39.2 |
Arcus Biosciences Stock Price History Chart
There are several ways to analyze Arcus Stock price data. The simplest method is using a basic Arcus candlestick price chart, which shows Arcus Biosciences price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | February 27, 2024 | 20.18 |
| Lowest Price | April 19, 2024 | 14.59 |
Arcus Biosciences April 25, 2024 Stock Price Synopsis
Various analyses of Arcus Biosciences' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Arcus Stock. It can be used to describe the percentage change in the price of Arcus Biosciences from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Arcus Stock.| Arcus Biosciences Price Rate Of Daily Change | 1.00 | |
| Arcus Biosciences Price Action Indicator | 0.11 | |
| Arcus Biosciences Price Daily Balance Of Power | (0.06) |
Arcus Biosciences April 25, 2024 Stock Price Analysis
Arcus Stock Price History Data
The price series of Arcus Biosciences for the period between Fri, Jan 26, 2024 and Thu, Apr 25, 2024 has a statistical range of 5.59 with a coefficient of variation of 9.32. The price distribution for the period has arithmetic mean of 16.95. The median price for the last 90 days is 16.73.| Open | High | Low | Close | Volume | ||
04/25/2024 | 15.49 | 15.85 | 14.71 | 15.43 | ||
| 04/24/2024 | 15.49 | 15.85 | 14.71 | 15.43 | 524,078 | |
| 04/23/2024 | 14.77 | 15.62 | 14.57 | 15.50 | 582,461 | |
| 04/22/2024 | 14.67 | 15.19 | 14.51 | 14.68 | 450,974 | |
| 04/19/2024 | 14.77 | 15.19 | 14.10 | 14.59 | 597,302 | |
| 04/18/2024 | 14.74 | 14.94 | 14.51 | 14.84 | 913,975 | |
| 04/17/2024 | 15.95 | 16.04 | 14.79 | 14.84 | 791,444 | |
| 04/16/2024 | 16.32 | 16.62 | 15.85 | 15.87 | 329,031 | |
| 04/15/2024 | 16.56 | 16.66 | 16.03 | 16.29 | 433,335 | |
| 04/12/2024 | 17.21 | 17.50 | 16.17 | 16.58 | 492,167 | |
| 04/11/2024 | 16.92 | 17.37 | 16.66 | 17.29 | 378,251 | |
| 04/10/2024 | 16.91 | 17.12 | 16.50 | 16.73 | 507,743 | |
| 04/09/2024 | 17.04 | 17.64 | 16.83 | 17.45 | 495,332 | |
| 04/08/2024 | 17.41 | 17.56 | 16.69 | 16.97 | 285,883 | |
| 04/05/2024 | 17.08 | 17.35 | 16.61 | 17.34 | 496,895 | |
| 04/04/2024 | 17.80 | 18.06 | 17.21 | 17.27 | 580,123 | |
| 04/03/2024 | 17.62 | 17.84 | 17.00 | 17.69 | 564,484 | |
| 04/02/2024 | 18.03 | 18.27 | 17.57 | 17.72 | 891,425 | |
| 04/01/2024 | 18.78 | 18.85 | 18.22 | 18.48 | 514,782 | |
| 03/28/2024 | 18.30 | 19.11 | 18.18 | 18.88 | 744,391 | |
| 03/27/2024 | 16.90 | 18.54 | 16.64 | 18.21 | 1,005,729 | |
| 03/26/2024 | 16.66 | 16.75 | 16.31 | 16.65 | 917,496 | |
| 03/25/2024 | 16.47 | 16.69 | 16.10 | 16.47 | 578,538 | |
| 03/22/2024 | 17.15 | 17.22 | 16.37 | 16.43 | 574,806 | |
| 03/21/2024 | 17.48 | 18.08 | 17.22 | 17.24 | 620,114 | |
| 03/20/2024 | 17.19 | 17.67 | 17.01 | 17.49 | 485,700 | |
| 03/19/2024 | 17.16 | 17.66 | 17.03 | 17.30 | 568,792 | |
| 03/18/2024 | 18.92 | 18.98 | 17.16 | 17.22 | 1,002,690 | |
| 03/15/2024 | 18.20 | 19.18 | 18.09 | 18.98 | 1,640,378 | |
| 03/14/2024 | 18.77 | 18.93 | 18.03 | 18.32 | 762,965 | |
| 03/13/2024 | 18.57 | 19.13 | 18.57 | 19.05 | 747,493 | |
| 03/12/2024 | 18.95 | 19.01 | 18.27 | 18.64 | 828,467 | |
| 03/11/2024 | 18.05 | 19.35 | 18.05 | 19.01 | 1,283,578 | |
| 03/08/2024 | 18.19 | 18.50 | 17.76 | 17.99 | 486,417 | |
| 03/07/2024 | 19.43 | 19.69 | 17.86 | 17.92 | 596,068 | |
| 03/06/2024 | 19.00 | 19.38 | 18.64 | 19.36 | 521,565 | |
| 03/05/2024 | 18.81 | 19.13 | 18.51 | 18.78 | 516,396 | |
| 03/04/2024 | 19.36 | 19.36 | 18.50 | 19.01 | 538,581 | |
| 03/01/2024 | 19.20 | 19.60 | 18.95 | 19.10 | 877,827 | |
| 02/29/2024 | 19.55 | 20.00 | 19.00 | 19.13 | 1,001,626 | |
| 02/28/2024 | 19.88 | 20.11 | 19.13 | 19.15 | 749,207 | |
| 02/27/2024 | 19.71 | 20.31 | 19.49 | 20.18 | 982,949 | |
| 02/26/2024 | 19.50 | 20.17 | 19.28 | 19.66 | 1,014,412 | |
| 02/23/2024 | 19.51 | 19.68 | 18.80 | 19.53 | 1,284,423 | |
| 02/22/2024 | 17.00 | 19.96 | 16.97 | 19.67 | 3,513,425 | |
| 02/21/2024 | 16.39 | 16.61 | 16.07 | 16.41 | 512,903 | |
| 02/20/2024 | 16.55 | 17.04 | 15.93 | 16.60 | 2,172,926 | |
| 02/16/2024 | 16.15 | 16.89 | 16.03 | 16.80 | 935,495 | |
| 02/15/2024 | 16.13 | 16.51 | 15.98 | 16.41 | 1,002,343 | |
| 02/14/2024 | 15.48 | 16.08 | 15.27 | 15.96 | 628,171 | |
| 02/13/2024 | 15.77 | 15.85 | 15.13 | 15.27 | 893,056 | |
| 02/12/2024 | 16.13 | 16.91 | 15.91 | 16.46 | 945,173 | |
| 02/09/2024 | 15.30 | 16.12 | 15.22 | 15.81 | 874,724 | |
| 02/08/2024 | 14.83 | 15.32 | 14.74 | 15.21 | 672,912 | |
| 02/07/2024 | 15.31 | 15.31 | 14.76 | 14.83 | 632,455 | |
| 02/06/2024 | 15.16 | 15.61 | 15.13 | 15.32 | 606,865 | |
| 02/05/2024 | 14.80 | 15.40 | 14.76 | 15.22 | 677,527 | |
| 02/02/2024 | 15.55 | 15.72 | 14.62 | 14.96 | 898,694 | |
| 02/01/2024 | 15.92 | 16.41 | 15.50 | 15.85 | 1,428,303 | |
| 01/31/2024 | 15.70 | 16.10 | 15.12 | 15.14 | 1,290,139 | |
| 01/30/2024 | 16.11 | 16.77 | 15.17 | 15.72 | 2,115,220 |
About Arcus Biosciences Stock history
Arcus Biosciences investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Arcus is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Arcus Biosciences will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Arcus Biosciences stock prices may prove useful in developing a viable investing in Arcus Biosciences
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 74 M | 57.8 M | |
| Net Loss | -240.3 M | -228.3 M |
Arcus Biosciences Quarterly Net Working Capital |
|
Arcus Biosciences Stock Technical Analysis
Arcus Biosciences technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Portfolio Manager Now
Portfolio ManagerState of the art Portfolio Manager to monitor and improve performance of your invested capital |
| All Next | Launch Module |
Arcus Biosciences Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Arcus Biosciences' price direction in advance. Along with the technical and fundamental analysis of Arcus Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Arcus to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0258 | |||
| Jensen Alpha | (0.16) | |||
| Total Risk Alpha | (0.42) | |||
| Sortino Ratio | 0.0079 | |||
| Treynor Ratio | 0.0311 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Arcus Biosciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in employment. For more information on how to buy Arcus Stock please use our How to Invest in Arcus Biosciences guide.You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Complementary Tools for Arcus Stock analysis
When running Arcus Biosciences' price analysis, check to measure Arcus Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Arcus Biosciences is operating at the current time. Most of Arcus Biosciences' value examination focuses on studying past and present price action to predict the probability of Arcus Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Arcus Biosciences' price. Additionally, you may evaluate how the addition of Arcus Biosciences to your portfolios can decrease your overall portfolio volatility.
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins |
Is Arcus Biosciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Arcus Biosciences. If investors know Arcus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Arcus Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (4.15) | Revenue Per Share 1.581 | Quarterly Revenue Growth (0.09) | Return On Assets (0.17) | Return On Equity (0.55) |
The market value of Arcus Biosciences is measured differently than its book value, which is the value of Arcus that is recorded on the company's balance sheet. Investors also form their own opinion of Arcus Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Arcus Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Arcus Biosciences' market value can be influenced by many factors that don't directly affect Arcus Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Arcus Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Arcus Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Arcus Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.